Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06773650

Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance

Lactose Intolerance: a Guide to Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation

Status
Recruiting
Phase
Study type
Observational
Enrollment
385 (estimated)
Sponsor
European Institute of Oncology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM). It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible). The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.

Conditions

Interventions

TypeNameDescription
OTHERCompletion of online surveyThe online survey aims to reach a representative sample of the Italian population to identify their knowledge regarding LI

Timeline

Start date
2025-01-08
Primary completion
2026-01-01
Completion
2026-01-01
First posted
2025-01-14
Last updated
2025-01-14

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06773650. Inclusion in this directory is not an endorsement.